Protecting cardiorenal function in patients with T2DM
Seminar
•
AstraZeneca
About the CPD course
This highly practical presentation provides information for HCPs in primary care practice about how to manage those in their care with type 2 diabetes mellitus (T2DM) and risk of cardiorenal dysfunction. Providing tools; acronyms; advice and data; this presentation includes a deep dive into available treatments for T2DM. It also equips HCPs to best support those in their care; with guidance on productive consultations; to ensure people with T2DM are being treated for cardiorenal risk in their management.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.
